Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NeutrArt

K-Number: K201872 · 2021-01-05

Decision Date2021-01-05
Product CodeFPA
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

NeutrArt is a medical device manufactured by Asset Medikal Tasarim As.. It received FDA 510(k) clearance on 2021-01-05 under approval number K201872. The device is classified under product code FPA. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NeutrArt?

NeutrArt is a medical device that received FDA 510(k) clearance on 2021-01-05. It is manufactured by Asset Medikal Tasarim As.. The 510(k) number is K201872.

When was NeutrArt approved by the FDA?

NeutrArt received FDA 510(k) clearance on 2021-01-05, under approval number K201872.

What company makes NeutrArt?

NeutrArt is manufactured by Asset Medikal Tasarim As..

What is the FDA product code for NeutrArt?

The FDA product code for NeutrArt is FPA.

Other Devices by Asset Medikal Tasarim As.

Related Devices (Code: FPA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.